Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613117 · ClinicalTrials.gov registry record · NA
Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT02613117: Completed NA study, sponsored by Procter and Gamble.
NCT02613117 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02613117, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
This study will assess the oral tolerability and immediate post-treatment safety of topical application for two marketed oxalate products as initial care in dental patients to treat or prevent tooth sensitivity pain that may be attributed to dentinal hypersensitivity.
Primary Outcome
Questionnaire indicating the frequencies of using various oral hygiene products by subjects at 5 different dental practices.
Interventions
- DRUG Stannous fluoride paste
- DEVICE Potassium Oxalate Gel
- DEVICE Potassium Oxalate Liquid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02613117 record still lists
NCT02613117 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Stannous fluoride paste is the first listed.
NCT02613117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02613117 about?
NCT02613117 is a clinical study titled "Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity". This study will assess the oral tolerability and immediate post-treatment safety of topical application for two marketed oxalate products as initial care in dental patients to treat or prevent tooth sensitivity pain that may be attributed to dentinal hypersensitivity.
What is the current status of trial NCT02613117?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2015-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02613117?
The interventions under investigation include: Stannous fluoride paste (DRUG), Potassium Oxalate Gel (DEVICE), Potassium Oxalate Liquid (DEVICE).
Who is sponsoring clinical trial NCT02613117?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02613117's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia